CSPG4 and chondrosarcoma: The immunotherapeutic significance of CSPG4 in chondrosarcoma has not yet been explored and therefore we evaluated its efficacy as a potential target in chondrosarcoma immunotherapy by assessing the expression of CSPG4 in a large series of surgically removed conventional and dedifferentiated chondrosarcoma.